Bharat Parenterals Ltd

Bharat Parenter. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bharat Parenterals Ltd

₹ 1,249 0.09%
20 May 10:17 a.m.
bplindia.in BSE: 541096
About

Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations[1]

Key Points

Business Overview:[1]
BPL is a Gujarat-based WHO GMP & an ISO 10002: 2014, 9001: 2015 certified pharmaceutical company. It manufactures over 800 products spread over 20+ different categories including General Products, β-Lactum/ Cephalosporin Products, Formulations in the form of Tablets, Capsules, Liquid- orals, Ointments, Creams, Lotions, and most importantly Powdered Injections and small Volume Parenterals both in Ampoules and Vials.

Website BSE
  • Market Cap ₹ 861 Cr.
  • Current Price ₹ 1,249
  • High / Low ₹ 1,667 / 880
  • Stock P/E
  • Book Value ₹ 468
  • Dividend Yield 0.08 %
  • ROCE -1.82 %
  • ROE -2.51 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 2.67 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -0.78% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.9.54 Cr.
  • Company has high debtors of 159 days.
  • Promoter holding has decreased over last 3 years: -6.67%
  • Working capital days have increased from 103 days to 149 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
50.97 69.91 59.81 59.82 67.82 92.51 71.63 72.26 103.98 116.00 64.62 65.19 99.62
44.75 59.46 55.49 53.21 66.82 88.02 79.29 68.62 101.75 102.22 63.79 63.45 100.14
Operating Profit 6.22 10.45 4.32 6.61 1.00 4.49 -7.66 3.64 2.23 13.78 0.83 1.74 -0.52
OPM % 12.20% 14.95% 7.22% 11.05% 1.47% 4.85% -10.69% 5.04% 2.14% 11.88% 1.28% 2.67% -0.52%
0.31 2.10 2.60 1.26 2.64 2.54 4.21 2.94 1.93 1.06 3.53 1.33 3.63
Interest 0.80 0.89 0.63 0.58 1.13 2.77 2.91 3.33 3.94 3.69 3.11 2.90 2.85
Depreciation 1.44 1.58 1.75 1.82 3.87 9.03 9.01 8.76 8.52 8.60 8.56 8.46 8.63
Profit before tax 4.29 10.08 4.54 5.47 -1.36 -4.77 -15.37 -5.51 -8.30 2.55 -7.31 -8.29 -8.37
Tax % 47.09% 30.46% 46.48% 33.46% 88.24% 85.32% 13.92% 43.01% 13.61% 134.12% 17.65% 16.77% -2.51%
2.27 7.01 2.43 3.64 -2.56 -8.84 -17.51 -7.88 -9.44 -0.87 -8.60 -9.67 -8.16
EPS in Rs 4.31 13.02 6.05 6.50 -0.52 1.96 -11.50 -2.42 -6.86 11.94 -10.49 -6.37 -6.96
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
124 111 137 220 228 205 212 218 261 340 345
114 105 124 191 200 179 183 198 234 337 330
Operating Profit 10 7 12 29 28 25 29 20 27 4 16
OPM % 8% 6% 9% 13% 12% 12% 14% 9% 10% 1% 5%
5 8 7 13 11 9 7 12 5 11 10
Interest 1 1 1 1 1 1 1 3 4 13 13
Depreciation 4 6 6 6 6 6 7 6 9 35 34
Profit before tax 9 7 13 35 33 27 28 24 19 -34 -21
Tax % 31% 8% 29% 39% 26% 25% 25% 33% 44% 29% 27%
6 7 9 21 24 20 21 16 11 -44 -27
EPS in Rs 11.26 12.03 15.92 37.09 42.13 35.59 36.45 28.47 24.95 -18.33 -11.88
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 3% 4% -5% -8%
Compounded Sales Growth
10 Years: 11%
5 Years: 11%
3 Years: 17%
TTM: 1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 34%
Stock Price CAGR
10 Years: %
5 Years: 26%
3 Years: 56%
1 Year: 14%
Return on Equity
10 Years: 7%
5 Years: 3%
3 Years: -1%
Last Year: -3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 6 6 6 6 6 6 6 6 7 7
Reserves 51 58 67 88 112 138 160 177 191 324 315
19 6 9 5 1 12 18 50 158 180 146
44 40 50 60 68 43 42 118 149 138 145
Total Liabilities 120 110 132 159 188 199 226 350 504 649 613
35 31 34 35 33 45 41 42 211 252 256
CWIP 0 0 0 1 12 0 26 99 25 31 34
Investments 0 1 1 1 0 43 11 0 0 5 6
85 79 98 121 142 111 148 209 268 360 317
Total Assets 120 110 132 159 188 199 226 350 504 649 613

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 -2 6 20 14 24 -1 22 -5 -27 38
0 -2 -8 -9 -13 -43 -7 -78 -105 -137 9
0 -8 4 -4 -3 10 9 61 110 156 -47
Net Cash Flow 0 -11 2 7 -1 -8 2 4 1 -8 1
Free Cash Flow 0 -4 -2 12 -0 24 -40 -68 -108 -56 -1
CFO/OP 0% -8% 73% 107% 87% 123% 16% 150% 18% -444% 305%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 130 143 157 106 127 121 126 188 198 184 159
Inventory Days 62 70 60 59 71 61 56 100 142 142 162
Days Payable 171 168 110 83 104 71 64 136 137 146 122
Cash Conversion Cycle 21 45 107 82 93 111 118 152 202 180 199
Working Capital Days 8 64 78 73 89 106 148 91 81 79 149
ROCE % 11% 18% 39% 31% 20% 17% 11% 7% -4% -2%

Insights

In beta
Mar 2019 Mar 2020 Mar 2022 Mar 2025
Export Presence (Number of Countries)
Number ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of Product Dossiers / Approved Products
Number ・Standalone data
Domestic Field Force (Varenyam Healthcare)
Number of MRs
Hospital Reach (Domestic)
Number of Hospitals
Manufacturing Lines (BPL Standalone)
Number ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
73.84% 73.84% 73.84% 73.27% 73.27% 65.35% 67.20% 67.20% 67.19% 67.19% 67.19% 67.17%
0.00% 0.00% 0.00% 0.00% 0.00% 0.08% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%
0.01% 0.01% 0.01% 0.01% 0.01% 0.57% 0.54% 0.54% 0.54% 0.54% 0.54% 1.07%
26.16% 26.15% 26.15% 26.72% 26.72% 33.98% 32.16% 32.15% 32.16% 32.16% 32.17% 31.65%
No. of Shareholders 2,4852,4812,3972,4972,7082,7483,1163,1773,2313,2053,1723,095

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • May 2026
    Transcript
    AI Summary
    PPT
  • Jan 2026
    Transcript
    AI Summary
    PPT
  • Nov 2025
    Transcript PPT
  • Jul 2025
    Transcript
    AI Summary
    PPT
  • May 2025
    Transcript
    PPT
  • May 2024
    Transcript
    AI Summary
    PPT
  • Feb 2024
    Transcript
    AI Summary
    PPT